This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Azwell Inc., Nippon Shoji Kaisha Ltd.. Active years: 2000-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2001
Title: Kenji Kawanishi: Innovator in Pharmaceutical Chemistry
Introduction
Kenji Kawanishi is a notable inventor based in Osaka, Japan, recognized for his contributions to the field of pharmaceutical chemistry. With a total of two patents, he has made significant strides in developing innovative pharmaceutical compounds.
Latest Patents
Kawanishi's latest inventions include two important patents. The first is the "Process for producing piperazinesulfonamide derivatives and salts thereof," which outlines a method for efficiently preparing piperazinesulfonamide derivatives, important in various pharmaceutical applications. The second patent is focused on a "Pyrimidine compound and anti-rotavirus composition," which details a pyrimidine compound with superior anti-rotavirus action. This compound shows promise for the prophylaxis and treatment of rotaviral diseases, emphasizing its potential impact on public health.
Career Highlights
Throughout his career, Kenji Kawanishi has worked with reputable companies such as Nippon Shoji Kaisha Ltd. and Azwell Inc. His roles in these organizations have allowed him to apply his innovative ideas and focus on pharmaceutical development, contributing to advancements in drug formulations.
Collaborations
Kawanishi has collaborated with notable colleagues, including Yoichiro Ohta and Masakatsu Hisaki. These partnerships have fostered a creative environment that has led to breakthroughs in the development of new pharmaceutical compounds.
Conclusion
Kenji Kawanishi is a distinguished inventor whose work in pharmaceutical chemistry continues to influence the industry. His patents reflect a commitment to scientific innovation and advancements in healthcare, particularly in the fight against viral diseases. As he continues to develop new solutions, Kawanishi remains a key figure in the world of pharmaceutical research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile